Acumen Pharmaceuticals, Inc. (ABOS)
Market Open
11 Sep, 13:31
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 98
+0.12
+4.1958%
$
228.24M Market Cap
- P/E Ratio
- Div Yield
5,903 Volume
- Eps
$ 2.86
Previous Close Want to track ABOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Acumen Pharmaceuticals, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BG Bart Gancher Intech Investment Management LLC | 10,446 | $23,921.34 | $25,436.01 | $1,514.67 | 6.33% |
 Joseph Castro Nuveen LLC | 63,355 | $145,082.95 | $180,878.52 | $35,795.57 | 24.67% |
 Taro Kuriyama Axq Capita LLP | 24,426 | $57,645.09 | $54,714.24 | -$2,930.85 | -5.08% |
 Daniel Ronan Catalyst Financial Partners LLC | 89,699 | $431,452 | $192,852.85 | -$238,599.15 | -55.3% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 39 | $89.31 | $110.56 | $21.25 | 23.79% |
| PIL PFG Investments LLC PFG Investments LLC | 94,250 | $212,142 | $269,555 | $57,413 | 27.06% |
 Christopher C. Powers Farther Finance Advisors, LLC | 200 | $232 | $430 | $198 | 85.34% |
| RJ Rebecca Judd Pathstone Holdings, LLC | 859,110 | $1.74M | $2.16M | $411,838.94 | 23.61% |
 Mark Schafer Police & Firemen's Retirement System of New Jersey | 19,393 | $44,409.97 | $62,348.49 | $17,938.52 | 40.39% |
 Clune & Associates Ltd. Clune & Associates Ltd. | 16,500 | $28,380 | $53,047.5 | $24,667.5 | 86.92% |
